| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.48 | 0.0006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.0006 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |